<DOC>
	<DOC>NCT01809197</DOC>
	<brief_summary>The purpose of this study was to compare lens comfort on Day 30 for Air Optix® lenses cared for with OPTI-FREE® PureMoist® (OFPM) Multi Purpose Disinfecting Solution (MPDS) compared to Acuvue® Oasys® lenses cared for with habitual MPDS.</brief_summary>
	<brief_title>Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution</brief_title>
	<detailed_description>Prior to the 30-day study period, subjects were fitted with study lenses in a masked manner and underwent a run-in period of 4-8 days to adjust to the randomized lenses.</detailed_description>
	<mesh_term>Myopia</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<mesh_term>Hyperopia</mesh_term>
	<mesh_term>Presbyopia</mesh_term>
	<mesh_term>Refractive Errors</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Sign informed consent. Currently wearing weekly/monthly contact lenses on a daily wear basis, as specified in protocol. Willing to wear contact lenses on a daily wear basis for the duration of the study. Currently using a multipurpose solution, as specified in protocol. Vision correctable to 20/30 (Snellen) or better in each eye at distance at Visit 1. Willing to follow the study procedures and visit schedule. Other protocoldefined inclusion criteria may apply. Currently wearing Air Optix, Acuvue Oasys, or Acuvue Advance brand of lenses. Currently using any OptiFree brand of multipurpose solution. Must wear contact lenses on an extended wear (overnight) basis during the study. Known sensitivity or intolerance to POLYQUAD® or ALDOX preserved lens care products. Monocular (only one eye with functional vision), fit with only one lens, or monovision modality of wear. Use of additional lens care products other than a multipurpose solution within 7 days prior to Visit 1. Use of topical ocular overthecounter (OTC) or prescribed topical ocular medications, with the exception of contact lens rewetting drops, within 7 days prior to Visit 1. Any abnormal ocular condition observed during the Visit 1 slitlamp examination. Current or history of ocular infections (i.e., microbial keratitis, conjunctivitis) or severe inflammation (i.e., iritis, infiltrates) within the 6 months prior to Visit 1. Ocular surgery within the 12 months prior to Visit 1. Any systemic diseases at Visit 1 (including allergies, respiratory infections or colds) that affect the eye and could be exacerbated by use of contact lenses or contact lens solutions. Participation in any clinical study within 30 days of Visit 1. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Refractive error</keyword>
	<keyword>Myopia</keyword>
	<keyword>Hyperopia</keyword>
	<keyword>Astigmatism</keyword>
	<keyword>Presbyopia</keyword>
	<keyword>Contact lenses</keyword>
	<keyword>Contact lens solution</keyword>
	<keyword>Comfort</keyword>
</DOC>